AT02

DRUG2 trials

Sponsors

Dhp Korea Co., Ltd., Attralus, Inc.

Conditions

Amyloidosis; SystemicDry Eye SyndromesKeratoconjunctivitis Sicca

Phase 2

Efficacy and Safety Study of ATs in Patients With Dry Eye Syndrome

CompletedNCT00788229

Dhp Korea Co., Ltd.Dry Eye Syndromes, Keratoconjunctivitis Sicca

Start: 2008-11-30End: 2009-08-31Updated: 2010-04-02

A Study of AT-02 in Subjects With Systemic Amyloidosis.

Active, not recruitingNCT05951049

Attralus, Inc.Amyloidosis; Systemic

Start: 2023-09-21End: 2026-09-28Target: 120Updated: 2026-05-06